Expert Answers to HCP Questions on Pancreatic Cancer Treatment

In this episode, Michael J. Pishvaian, MD, PhD, and Rachna Shroff, MD, answer audience questions from a live CCO webinar focused on current best practices and emerging strategies in pancreatic cancer treatment, with questions including:

• What is your preferred regimen for neoadjuvant therapy in patients with resectable disease?
• How do you sequence therapy for patients with metastatic pancreatic cancer?
• How can you manage a patient who develops significant diarrhea with FOLFIRINOX?
• Are cisplatin and oxaliplatin equally efficacious for patients with BRCA-mutant disease?
• How should maintenance olaparib be used?

Presenters:

Michael J. Pishvaian, MD, PhD  
Associate Professor of Oncology
Director, Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs
NCR Kimmel Cancer Center at Sibley Memorial Hospital
John Hopkins University School of Medicine
Washington, DC

Rachna Shroff, MD
Associate Professor of Medicine
Chief, Section of GI Medical Oncology
Director, UACC Clinical Trials Office
The University of Arizona Cancer Center
Tucson, Arizona

 Content based on an online CME program supported by educational grants from Bristol-Myers Squibb and Ipsen Group.

Link to full program:
http://bit.ly/314BALT

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.